目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any threats toward leading players?

8 Company Profiles
8.1. Novartis AG
8.2. GSK plc.
8.3. AstraZeneca PLC
8.4. Pfizer Inc.

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: United Kingdom pharmaceuticals market value: $ billion, 2016-21
Table 2: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: United Kingdom pharmaceuticals market value forecast: $ billion, 2021-26
Table 4: United Kingdom pharmaceuticals market share: % share, by value, 2021
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: GSK plc.: key facts
Table 10: GSK plc.: Annual Financial Ratios
Table 11: GSK plc.: Key Employees
Table 12: GSK plc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: AstraZeneca PLC: Key Employees Continued
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: Annual Financial Ratios
Table 19: Pfizer Inc.: Key Employees
Table 20: Pfizer Inc.: Key Employees Continued
Table 21: United Kingdom size of population (million), 2017-21
Table 22: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 23: United Kingdom gdp (current prices, $ billion), 2017-21
Table 24: United Kingdom inflation, 2017-21
Table 25: United Kingdom consumer price index (absolute), 2017-21
Table 26: United Kingdom exchange rate, 2017-21

List of Figures
Figure 1: United Kingdom pharmaceuticals market value: $ billion, 2016-21
Figure 2: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: United Kingdom pharmaceuticals market value forecast: $ billion, 2021-26
Figure 4: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2021
Figure 10: United Kingdom pharmaceuticals market share: % share, by value, 2021